Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Home
Tags
Antibody-drug Conjugates
Tag: Antibody-drug Conjugates
BMS and Seattle Genetics Expand Evaluate Combination of Nivolumab + Brentuximab...
Peter Hofland, Ph.D
-
June 3, 2017
53rd ASCO – What to Expect?
Sonia Portillo
-
June 2, 2017
SGN-CD19A Demonstrates Encouraging Activity and Safety Profile in Patients with Acute...
Editorial Team
-
December 9, 2013
Phase I Trial of Novel Antibody-drug Conjugate SGN-LIV1A Initiated in LIV-1-Positive...
Editorial Team
-
October 24, 2013
Patients with Advanced HER2-Positive Breast Cancer Live Longer Without Their Disease...
Editorial Team
-
September 29, 2013
ADC Therapeutics and Genmab Agree to Develop Novel Antibody-drug Conjugate
Editorial Team
-
June 18, 2013
Ado-trastuzumab Emtansine, a New Targeted Medicine, Gives Patients a Survival Advantage:...
Editorial Team
-
February 24, 2013
The Next Advancements in Cancer Drug Development: Antibody-Drug Conjugates
Peter Hofland, Ph.D
-
June 14, 2012
Majority of Pediatric Patients with Hodgkin Lymphoma Achieve CR After Treatment...
Peter Hofland, Ph.D
-
September 24, 2011
Sanofi-Aventis In-licenses Therapeutic Antibody for the Treatment of Solid Cancers From...
Peter Hofland, Ph.D
-
January 29, 2011
1
...
4
5
6
Page 5 of 6
LATEST NEWS
The Impact of the Failure: HSBC’s Acquisition of SVB UK may offer New Opportunities...
Editorial Team
-
March 31, 2023
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical Cancer
Editorial Team
-
March 30, 2023
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial
Editorial Team
-
March 30, 2023
Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past
Julie Appleby
-
March 30, 2023
Oral Developability Assessment and Manufacturing Solution may Advance Targeted Protein Degraders
Editorial Team
-
March 29, 2023
X